Obs Medical Limited
- Active
- Small
- 26 years
- 7 employees
- £220,665 (cur assets)
- £198,687 (revenue)
- 0-1m
- Real address
- 3 directors
- 1 owner
- Solo founder
- Cirencester
Two conditions of three:
1.Turnover < £10.2 million
2.Balance sheet total < £5.1 million
3.Average number of employees < 50
Field of Operation
Summary
Obs Medical Limited is a private limited company registered in England/Wales with the registration number 03955861. The company was founded twenty six years ago on March 24, 2000, and registered at GL7 6JJ, England, Cirencester, Unit 14 Cirencester Office Park, Tetbury Road. The address is probably real as only one company are registered at the same address. Its status is active. The company operates in Professional services → Scientific and technical R&D. Officially, it has one owner or PSCs, three directors, and seven employees.
It's a small company as it met two conditions of three: turnover less than £10.2 million, balance sheet less than £5.1 million, employees less than 50. The last reported current assets is £220,665, and the revenue is £198,687.
WARNING: The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.
Ports, countries, transport, and price/kg were calculated by CorpSignals; non-official data, may contain errors.
Owners & PSC
-
Individual
- 10 years
- 2
- 75%+
-
Resident of Bermuda
Managers
-
Individual
- 8 years
-
Resident of Bermuda
-
Individual
- 8 years
-
Resident of United Kingdom
-
Individual
- 9 years
-
Resident of United Kingdom
Last reports
The latest confirmation statement submitted twelve days ago.
Last news
-
Confirmation statement made on 2026-07-28 with updatesDownload 10 pages pdf report
-
Statement of capital following an allotment of shares on 2026-06-30Download 3 pages pdf report
-
Statement of capital following an allotment of shares on 2026-05-21Download 3 pages pdf report
FAQ about Obs Medical Limited
Looking for leads in the UK?
Book a demo—see how CorpSignals can help you find UK leads.